Medicare Advantage
AHA Urges CMS to Rigorously Enforce New Policies to Safeguard MA Coverage
The Centers for Medicare & Medicaid Services Sept. 26 released premium and cost-sharing information for Medicare Advantage and Part D prescription drug plans for the 2024 calendar year.
The Health and Human Services Office of Inspector General Aug. 28 released a strategic plan to align its audits, evaluations, investigations and enforcement of managed care plans in Medicare Advantage and Medicaid.
In an Aug. 28 letter to House sponsors, the AHA voiced support for the GOLD Card Act of 2023 (H.R. 4968) that would exempt qualifying providers from prior authorization requirements under Medicare Advantage plans.
AHA voices support of the GOLD Card Act of 2023 (H.R. 4968).
The American Hospital Association would like to provide feedback on sections of H.R. 4822, the “Health Care Price Transparency Act of 2023,” as well as H.R. 3284, the “Providers and Payers COMPETE Act.”
A bipartisan group of 233 representatives and 61 senators called on the Centers for Medicare & Medicaid Service to enhance its proposal to streamline prior authorization processes in Medicare Advantage, Medicaid and the federally-facilitated Marketplace to require real-time electronic decision-…
AHA May 17 shared with the Homeland Security and Governmental Affairs Permanent Subcommittee on Investigations its concern that some MA plans inappropriately restrict beneficiary access to medically necessary covered services and urged Congress to increase its oversight of these plans.
AHA Statement to Senate Subcommittee on Medicare Advantage Delays and Denials
Several House and Senate committees will hold hearings this week on a variety of issues that affect hospitals and health systems.